At Johnson & Johnson Innovative Medicine, I built and activated the first Swedish Cell Therapy Brand Plan for 2026–2027, aligning a new cross-functional team around shared priorities and an integrated omnichannel strategy.
I direct commercialization and launch readiness across Sweden, Norway, Finland and Denmark, adapting regional plans to local access, compliance and treatment-center needs. I also manage Nordic marketing budgets, forecasts, vendors and investment priorities.
Earlier at Johnson & Johnson Innovative Medicine, I led brand and editorial planning in Neuroscience and Swedish execution of a public awareness campaign. I’m a pharmacist with an MBA from ESADE, and have also worked in pharmacy management and strategy consulting.

